Logo image of SBTX

SILVERBACK THERAPEUTICS INC (SBTX) Stock Analyst Ratings

NASDAQ:SBTX - Nasdaq - US82835W1080 - Common Stock - Currency: USD

5.87  +0.06 (+1.03%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to SBTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.1. This target is -13.12% below the current price.
SBTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SBTX.
In the previous month the buy percentage consensus was at a similar level.
SBTX was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

SBTX Historical Analyst RatingsSBTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.875.055.105.105.25 - -13.97% -13.12% -13.12% -10.56%

Related screens

SBTX Current Analyst RatingSBTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2021-11-12 SVB Leerink Maintains Outperform
2021-08-16 SVB Leerink Maintains Outperform
2021-05-27 JonesTrading Initiate Buy
2021-05-17 SVB Leerink Maintains Outperform
2021-04-06 SVB Leerink Maintains Outperform
2021-03-30 Stifel Maintains Buy